Top Markets
Coin of the day
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Clasificación en acciones #41089
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Precio por acción
$0.0202
Última sincronización: 2024-11-19
Capitalización bursátil
$44.67K
Cambio (1 día)
-0.49%
Cambio (1 año)
0.00%
País
IL
Comercio Notable Labs, Ltd. (NTBL)

Categoría

Historial del precio de la acción de Notable Labs, Ltd. (NTBL)
Precio más alto de cierre: $0.07 el 2024-11-01

Precio más bajo de cierre: $220.88 el 2014-10-01
Historial del precio de la acción de Notable Labs, Ltd. desde 2014 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2024 -97.63%
2023 -35.28%
2022 -94.02%
2021 21.62%
2020 45.36%
2019 14.25%
2018 -84.70%
2017 40.20%
2016 -5.03%
2015 -14.31%
2014 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$525.78 32.80%
US
$874.09 35.18%
NL
$746.78 9.21%
CH
$1.08K -6.68%
KR
$261.19 17.24%
BE